Patents by Inventor David Georges Zahra

David Georges Zahra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody with specificity for GM-CSF (II)
    Patent number: 9567398
    Abstract: The present invention relates to antibodies with specificity for granulocyte-macrophage colony stimulating factor (GM-CSF). More particularly, the invention relates to humanized monoclonal antibodies that bind specifically to human GM-CSF with high affinity. The invention also relates to nucleic acids encoding the antibodies, vectors for expression of these nucleic acids, and host cells for producing said antibodies. Further, the invention relates to the use of said antibodies in the diagnosis or treatment of autoimmune or inflammatory diseases.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: February 14, 2017
    Assignee: MERCK SERONO S.A.
    Inventors: Laurent Magnenat, Olivier Leger, Charles MacKay, David Georges Zahra
  • Antibody with specificity for GM-CSF (I)
    Patent number: 9567397
    Abstract: The present invention relates to antibodies with specificity for granulocyte-macrophage colony stimulating factor (GM-CSF). More particularly, the invention relates to humanized monoclonal antibodies that bind specifically to human GM-CSF with high affinity. The invention also relates to nucleic acids encoding the antibodies, vectors for expression of these nucleic acids, and host cells for producing said antibodies. Further, the invention relates to the use of said antibodies in the diagnosis or treatment of autoimmune or inflammatory diseases.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: February 14, 2017
    Assignee: MERCK SERONO S.A.
    Inventors: Laurent Magnenat, Olivier Leger, Charles Mackay, David Georges Zahra
  • ANTIBODY WITH SPECIFICITY FOR GM-CSF (II)
    Publication number: 20140065163
    Abstract: The present invention relates to antibodies with specificity for granulocyte-macrophage colony stimulating factor (GM-CSF). More particularly, the invention relates to humanized monoclonal antibodies that bind specifically to human GM-CSF with high affinity. The invention also relates to nucleic acids encoding the antibodies, vectors for expression of these nucleic acids, and host cells for producing said antibodies. Further, the invention relates to the use of said antibodies in the diagnosis or treatment of autoimmune or inflammatory diseases.
    Type: Application
    Filed: November 17, 2011
    Publication date: March 6, 2014
    Inventors: Laurent Magnenat, Olivier Leger, Charles MacKay, David Georges Zahra
  • ANTIBODY WITH SPECIFICITY FOR GM-CSF (I)
    Publication number: 20140023641
    Abstract: The present invention relates to antibodies with specificity for granulocyte-macrophage colony stimulating factor (GM-CSF). More particularly, the invention relates to humanized monoclonal antibodies that bind specifically to human GM-CSF with high affinity. The invention also relates to nucleic acids encoding the antibodies, vectors for expression of these nucleic acids, and host cells for producing said antibodies. Further, the invention relates to the use of said antibodies in the diagnosis or treatment of autoimmune or inflammatory diseases.
    Type: Application
    Filed: November 17, 2011
    Publication date: January 23, 2014
    Applicant: Merck Serono S.A.
    Inventors: Laurent Magnenant, Olivier Leger, Charles Mackay, David Georges Zahra